Clinical trial · Observational
Chest Computed Tomography (CT) Screening Study With Antibody Testing
Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer
NCT01203579CI-TRIAL-00007229withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Due to lack of funding
Summary
Brief summary (as posted)
The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 75 Years
Show eligibility criteria text
* Persons 50-75 * Asymptomatic for lung cancer * Current or former (stopped smoking less than 10 years ago) cigarette smokers * History of cigarette smoking of at least 20 pack years * History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years). * Mentally competent individuals to sign an informed consent. * Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy. * A fully informed signed consent form must have been obtained.
References
Publications (0)
Data not yet available
No reference posted for this study.